India to Australia: Ramipril Export Trade Route
India has recorded 166 verified shipments of Ramipril exported to Australia, representing a combined trade value of $2.3M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $13.7K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 42% of total export value with 69 shipments worth $947.6K USD. On the buying side, SUN PHARMA ANZ PTY LTD. is the largest importer in Australia with $385.8K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, IND SWIFT LIMITED, IND-SWIFT LIMITED — together control 84% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Ramipril corridor is one of India's established pharmaceutical export routes, with 166 shipments documented worth a combined $2.3M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's ramipril manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $13.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with ramipril's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 14 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #5 among India's top ramipril export destinations globally.
On the import side, key buyers of Indian ramipril in Australia include SUN PHARMA ANZ PTY LTD., ARROW PHARMACEUTICALS PTY LTD, SUN PHARMA ANZ PTY LTD and 18 others. SUN PHARMA ANZ PTY LTD. is the single largest importer with 32 shipments valued at $385.8K USD.
